Molecular Oncology

Research Frontiers in BCR-ABL Tyrosine Kinase Inhibitor Resistance

Molecular mechanisms of breakpoint cluster region-abelson leukemia viral oncogene homolog resistance including gatekeeper mutations and pathway bypass.

All Molecular Oncology PhD categories